U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 077533
Company: INVAGEN PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TERBINAFINE HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET;ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/02/2007 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/077533s000_ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/11/2025 SUPPL-17 Labeling-Package Insert, Labeling-Medication Guide

Label is not available on this site.

09/11/2025 SUPPL-14 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.

01/10/2016 SUPPL-12 Labeling-Package Insert, Labeling-Patient Package Insert

Label is not available on this site.

01/10/2016 SUPPL-10 Labeling-Package Insert, Labeling-Medication Guide

Label is not available on this site.

07/12/2012 SUPPL-5 Labeling-Patient Package Insert, Labeling-Package Insert

Label is not available on this site.

09/20/2011 SUPPL-3 Labeling-Container/Carton Labels, Labeling-Patient Package Insert, Labeling-Package Insert

Label is not available on this site.

Back to Top